Medical Practice Marketing: A Patient-First Strategy

The HIPAA marketing map

HIPAA defines marketing as a communication about a product or service that encourages recipients to purchase or use the product or service, and generally requires written authorization first. [HHS, HIPAA Privacy Rule marketing guidance]

Communications describing the covered entity's own health-related products or services, treatment communications, and care coordination or alternative-treatment recommendations are excepted from the marketing definition. [HHS]

Mapping every planned patient communication against these three categories before drafting a single message avoids the most common compliance mistake in clinic marketing, which is treating an authorization-required communication as if it were an ordinary service update.

• A covered entity may not sell PHI to third parties for their own purposes, and may not sell patient lists without authorization from each person. [HHS]
• If marketing involves direct or indirect remuneration from a third party, the authorization must state that remuneration is involved. [HHS]
• Face-to-face communications and promotional gifts of nominal value do not require authorization even if they are marketing. [HHS]

Claims and evidence standards

Health-benefit claims require competent and reliable scientific evidence, and testimonials cannot be used to make claims the advertiser could not substantiate directly. [FTC, Health Products Compliance Guidance]

None of the guidance above should be read as clinical advice; it addresses marketing, advertising, privacy, and patient education only, and any clinical question should go to a licensed provider.

Transparency expectations patients now bring

Since January 1, 2021 every U.S. hospital must publish a comprehensive machine-readable file of items and services plus a consumer-friendly display of shoppable services, with enforcement of updated CY 2026 requirements starting April 1, 2026. [CMS, Hospital Price Transparency]

Patients increasingly expect to find some version of this transparency on a practice's own site as well, even outside the hospital-specific mandate, and a clear pricing or estimate page tends to reduce friction at the point of scheduling.

Practices that build compliance into the workflow from the outset tend to spend less time on rework later, since retrofitting consent language or claim substantiation after publication is far more expensive than designing for it up front.

Local visibility for clinics and practitioners

Individual practitioners and departments within businesses, universities, hospitals, and government buildings may have separate profile pages, which matters for group practices structuring their local footprint. [Google, Guidelines for representing your business]

Assign clear ownership for compliance review inside the marketing function itself, rather than treating it as something legal handles entirely separately, since the fastest catches happen when the person writing the content already knows the rules.

Website fundamentals: structure, schema, accessibility

Build clear service pages with accurate structured data and genuine accessibility work, since both compliance posture and usability improve together when accessibility is treated as infrastructure rather than an afterthought.

Train every new hire who touches patient-facing marketing on this rulebook specifically, rather than assuming general marketing experience transfers cleanly, since the constraints in this category diverge sharply from ordinary consumer marketing practice.

Measurement without PHI leakage

FDA's Office of Prescription Drug Promotion exists to help ensure prescription drug promotion is truthful, balanced, and accurately communicated, reviewing promotional materials and issuing compliance letters where they are false or misleading, a useful reminder that measurement and claims discipline are linked. [FDA, OPDP]

Keep a running file of every claim made in marketing materials along with its supporting evidence, so a compliance review or an unexpected audit can be answered quickly rather than reconstructed after the fact.

A 12-month roadmap

Quarter one: map every patient communication against the HIPAA marketing definition. Quarter two: rebuild service pages with substantiated claims. Quarters three and four: layer in local visibility and measurement work.

Where guidance in this space is still evolving, as with tracking technology rules, default to the most conservative reading available rather than the most permissive one, since the cost of over-caution is far lower than the cost of a real violation.

Frequently asked questions

Primary sources

Policy and statistical claims in this guide are grounded in the sources below. Access dates and policy details can change, so verify regulated guidance before acting.

• HHS, HIPAA Privacy Rule marketing guidance
• FTC, Health Products Compliance Guidance
• CMS, Hospital Price Transparency
• FDA, Office of Prescription Drug Promotion
• Google, Guidelines for representing your business